Literature DB >> 15126177

Best's vitelliform macular dystrophy with pseudohypopyon: an optical coherence tomography study.

Gamze Men1, Figen Batioğlu, Seyhan Sonar Ozkan, Huban Atilla, Yasemin Ozdamar, Ozlem Aslan.   

Abstract

PURPOSE: To report optical coherence tomography (OCT) changes in Best's vitelliform macular dystrophy (BVMD) with pseudohypopyon.
DESIGN: Observational case report.
METHODS: Both eyes of a patient with BVMD showing pseudohypopyon were examined with OCT.
RESULTS: OCT demonstrated the presence of serous retinal elevation with normal appearing retinal pigment epithelium (RPE) superiorly, and broadening of the outer-retina-choroid-complex signal under retinal elevation, inferiorly.
CONCLUSIONS: OCT findings in our study suggest the accumulation of material under neurosensory retina in BVMD with pseudohypopyon.

Entities:  

Mesh:

Year:  2004        PMID: 15126177     DOI: 10.1016/j.ajo.2003.11.014

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Multimodal fundus imaging in Best vitelliform macular dystrophy.

Authors:  Daniela C Ferrara; Rogério A Costa; Stephen Tsang; Daniela Calucci; Rodrigo Jorge; K Bailey Freund
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04-23       Impact factor: 3.117

Review 2.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

3.  Analysis of retinal flecks in fundus flavimaculatus using optical coherence tomography.

Authors:  G Querques; N Leveziel; N Benhamou; M Voigt; G Soubrane; E H Souied
Journal:  Br J Ophthalmol       Date:  2006-06-05       Impact factor: 4.638

4.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa.

Authors:  Alice E Davidson; Ian D Millar; Jill E Urquhart; Rosemary Burgess-Mullan; Yusrah Shweikh; Neil Parry; James O'Sullivan; Geoffrey J Maher; Martin McKibbin; Susan M Downes; Andrew J Lotery; Samuel G Jacobson; Peter D Brown; Graeme C M Black; Forbes D C Manson
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.